Biogen Inc vs Packaging Corporation of America — how do they compare? Biogen Inc trades at $191.9 (market cap $30.86B), while Packaging Corporation of America trades at $226.04 (market cap $20.12B). The key difference: Biogen Inc is the larger of the two by market cap, and Packaging Corporation of America pays a 2.66% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.
| BIIB | PKG | |
|---|---|---|
Market Cap | $30.86B | $20.12B |
Sector | Health | Technology |
52-Week High | $216.63 | $246.31 |
52-Week Low | $122.68 | $191.41 |
Enterprise Value | $33.14B | $23.95B |
Dividend Yield | — | 2.66% |
Trailing returns across standard periods
Latest headlines on both assets
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Read more on BIIB →Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →